Harver Group Targets BioTech Bull
- Sunday, August 25, 2013, 19:00
- Uncategorized
- Add a comment
Synta Pharmaceuticals has a bullish outlook for Q3-Q4; insider buying indicates the company will be releasing positive research results and see a gain in returns.
http://www.1888pressrelease.com/harver-group-targets-biotech-bull-pr-487372.html
About the Author
admin123 has written 23409 stories on this site.
